Depressive Disorders - Japan

Japan

Revenue in the Depressive Disorders market is projected to reach €1.15bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.43%, resulting in a market volume of €1.17bn by 2028.
In global comparison, most revenue will be generated in the United States (€5,807.00m in 2024).
In relation to total population figures, per person revenues of €0.33k are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Depressive Disorders market in Japan is experiencing significant growth and development.

Customer preferences: Japanese consumers are increasingly seeking mental health treatment and are more open to discussing and seeking help for depressive disorders. This shift in customer preferences is driven by several factors, including a growing awareness of mental health issues, changing social attitudes towards mental health, and an aging population that is more prone to depressive disorders. As a result, there is a growing demand for effective treatments and therapies for depressive disorders in Japan.

Trends in the market: One of the key trends in the Depressive Disorders market in Japan is the increasing adoption of pharmacological treatments. Antidepressant medications are becoming more widely prescribed by healthcare professionals, as they are considered effective in managing depressive symptoms. The availability and accessibility of these medications have also improved, contributing to their increased usage. Additionally, there is a growing trend towards combining pharmacological treatments with other forms of therapy, such as cognitive-behavioral therapy, to provide a comprehensive approach to managing depressive disorders.Another trend in the market is the rise of digital mental health solutions. Mobile applications and online platforms that offer mental health support and therapy are gaining popularity among Japanese consumers. These digital solutions provide convenience and accessibility, allowing individuals to access support and treatment from the comfort of their homes. The COVID-19 pandemic has further accelerated the adoption of digital mental health solutions, as people seek alternatives to in-person therapy sessions.

Local special circumstances: Japan has a unique cultural context that influences the Depressive Disorders market. The concept of "karoshi," which refers to death by overwork, is prevalent in Japanese society. This cultural phenomenon contributes to high levels of stress and burnout among workers, increasing the risk of depressive disorders. The Japanese government has recognized the impact of karoshi and has implemented policies to address work-related stress and promote work-life balance. This focus on mental health in the workplace has created opportunities for mental health service providers and contributed to the growth of the Depressive Disorders market.

Underlying macroeconomic factors: Japan has been facing economic challenges in recent years, including a shrinking population and low birth rate. These factors have implications for the Depressive Disorders market. An aging population is more susceptible to depressive disorders, leading to increased demand for treatments and therapies. Additionally, the government has been investing in healthcare infrastructure and initiatives to address mental health issues, further driving the growth of the market. The combination of these macroeconomic factors and changing societal attitudes towards mental health has created a favorable environment for the development of the Depressive Disorders market in Japan.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.